We use cookies to ensure that we give you the best experience on our website. Ok ABOUT PIRAMAL ABOUT PIRAMAL HISTORY LEADERSHIP TEAM PATIENT CENTRICITY ENVIRONMENT, HEALTH & SAFETY QUALITY ANTI-CAPITAL PUNISHMENT Home About Piramal Mr. Ajay Piramal Chairman - Piramal Group PIRAMAL GROUP Mr. Ajay Piramal is one of India’s leading industrialists and philanthropists, and Chairman of the Piramal Group. Piramal Group is a global business conglomerate with diverse interests in pharmaceuticals, financial services and real estate, with offices in 30 countries and its products sold in more than 100 markets. The Group has a strong track record of robust sustained partnerships with several marquee global investors and partners. Mr. Piramal is regarded as a torchbearer for responsible entrepreneurship, with a strong focus on ‘Doing Well and Doing Good’, a philosophy that has created long-term value for the Group’s stakeholders and the community as a whole A firm believer in the tenets of the Bhagvad Gita, Mr. Piramal is a passionate advocate of trusteeship and responsible business ethos. He is deeply invested in unblocking India’s socio-economic potential through the Piramal Foundation, and is an ardent promoter of social entrepreneurship. Mr. Piramal actively steers the Group’s involvement in various social impact initiatives through the Piramal Foundation, to develop innovative long term and scalable solutions to resolve issues that are critical roadblocks towards unlocking India’s economic potential. The Foundation currently works across 25 states and has impacted over 112 million lives, mostly in partnership with state governments, through Piramal Swasthya, Piramal Sarvajal and Piramal School of Leadership. Piramal Foundation has partnered with NITI Aayog, India’s foremost think-tank, in 25 Aspirational Districts across 7 states in India, to improve human development indicators across Healthcare & Nutrition and Education, amongst marginalised sections of society. Mr. Piramal holds key positions on the Boards of several companies and prestigious institutions. He serves on the Harvard Business School’s Board of Dean’s Advisors, is co-Chair of the UK-India CEO Forum and Non-Executive Director of Tata Sons Ltd. Passionate about contributing to education in India, Mr. Piramal also serves as President and Chairman of Anant National University and Chairman of the Pratham Education Foundation. He has been conferred with several national and international recognitions including: Outstanding Performance at the 9th Asia Pacific Entrepreneurship Awards (2018); International Advertising Association’s (IAA) Business Leader of the Year Award (2018); Asia Pacific Entrepreneurship Awards (APEA) – ‘Special Achievement Award’ Category'(2018); CNBC India Business Leader of the Year (2018) and CNBC Asia Business Leader Award (2017) for his visionary leadership; Hurun India Philanthropy List (2017); SEN Sustainability Award – Philanthropy and Best of Best – instituted by World Presidents’ Organisation (2015); Corporate Citizen of the Year award by AIMA Managing India Awards (2016); ‘Outstanding Philanthropist’ (2014 and 2013) by Forbes Philanthropy Awards; ‘Business Leader of the Year’ by the Indo-American Chamber of Commerce; and ‘Entrepreneur of the Year’ (2006) by the UK Trade and Investment Council. Mr. Piramal holds an Honours degree in Science from Mumbai University and a Master’s degree in Management Studies from the Jamnalal Bajaj Institute of Management Studies. He has completed an Advanced Management Programme from the Harvard Business School, and has been conferred with an Honorary Doctorate in Philosophy (D. Phil) by Amity University, India, and an Honorary Doctor of Science (Honoris Causa) Degree by IIT-Indore. Peter DeYoung CEO, Piramal Global Pharma, Piramal Pharma Ltd. PIRAMAL PHARMA SOLUTIONS Piramal Pharma Solutions is the Contract Development and Manufacturing arm of Piramal Pharma Ltd., with operations across North America, Europe and Asia. We are a global leader in integrated solutions and offer a unique platform of services across the drug lifecycle – from drug discovery and development to commercial manufacturing of drug substances and drug products. Our capability as an integrated service provider & experience with various technologies enable us to serve innovator and generic companies worldwide. With accreditations from regulatory bodies in US, Europe & Japan, our development centres and manufacturing sites across the globe have a pool of over 700 scientists committed to research & development programs. At Piramal Pharma Solutions, our focus is on serving as a ‘Customer Centric’ organization. We accomplish this by keeping the “Pulse of the Customer” at the heart of our mission. We are constantly evolving our internal processes, communication and program management in order to continue to provide the best service to our clients. We have been recognized by several global industry forums and have received awards for our quality, reliability, regulatory compliance and adherence to EHS guidelines. OUR LEADERSHIP TEAM OUR CORE VALUES At Piramal Group, our core values of Knowledge, Action, Care and Impact have been an integral part of our guiding philosophy. These values represent our deeply held beliefs and define us at the individual as well as organizational levels. Shaped by our past and collective experience, they determine how we engage with others, what we identify with and what we love and value. We encourage a deep understanding of these core values and believe in institutionalizing them across our entire organization so as to build a distinctive Piramal culture. To enhance value for pharmaceutical companies by being a trusted partner to reduce the burden of disease. KNOWLEDGE ACTION CARE IMPACT KNOWLEDGE Expertise - Strive for deeper understanding of our domain. Innovation - We aspire to do things creatively. 2021 Piramal Pharma Solutions Sitemap Privacy Policy Disclaimer